President’s Message
Members
Country Overview
- Action Program for Expanding Generic Medicine Use (October, 2007)
- Basic Policy for Fundamental Reform of the Drug Pricing System in Japan 2016
- Basic Policy on Economic and Fiscal Management and Reform 2017
- Basic Policy on Economic and Fiscal Managemnet and Reform 2015
- Bioequivalence (BE)
- Biosimilar Products
- Estimates of National Medical Care Expenditure
- Generic Share (%) by MHLW Drug Price Survey conducted biennially
- Generic Share (%) investigated by JGA and IQVIA Japan
- Population
- Socilal Security Expenditure by Category
- Roadmap for Further Promotion of Generic Medicine Use(April, 2013)
- Statistics of Production by Pharmaceutical Industry